Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the belief that AI will ...

CNN's Wolf Blitzer leveled his inquisitive gaze at me and asked the biggest question in tech, “Is AI an existential threat to humanity?" I smiled confidently and assured Wolf, "No, I don't think it is ...

What was revolutionary about the clonal-selection theory as a solution to the specificity-of-antibody problem? N. Av Mitchison. Biology in the 1950s was coming to terms with 'DNA and all that'. We saw ...

A merge sort uses smaller, ordered lists which are easier to sort and merge than larger lists. It is usually more efficient and quicker than the bubble sort. It is more complex to code. It will still ...